• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/10

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

10 Cards in this Set

  • Front
  • Back
CD8+ T cells vs. NK Cells
Both protect host from pathogen, and kill bad cells using similar cytotoxic chemicals and cytokines. They differ in that T cells have T receptors (VDJ) that recognize specific antigen and MHC abd NK cells use a variety of receptors that are encoded by allelic variation and not recombination, and can recognize absence of Class I (lack of self) an stressed cells.
Cytotoxic T cell Balance
Too much can cause AID, GVHD, Transplant rejection, diabetes. Too little can cause immunodeficiency like CHS and FHL.
Cytotoxicity vs. Immune modulation
C: granzyme, preforin, death receptor pathway
I: IFN-Y TNF. chemokines 3,4,5. IL 10 as well GM CSF
Death Pathway
The T cell binds to the target cell enhaging T cell receptor and CD8 with MHC. This causes the release of preforin and grnazymes taken up by the target cell. Preforin disrupts the cell membrnae, granzyme A breaks down DNA and granzyme B activates BID which will activate apoptoisis. The T cell will also release Fas-ligand activating capsases. Fas ligand can bind Fas on the target cell or immune cell, thus terminating the immune response (fratreicide)

Another method is the TRAIL pathway which uses TNF to activate capsases. Trail from T cell binds TRAIL-R and leads to FADD binding and then capsase 8 binding.
Licensing
After dendritic cells activate T cell, they must aquire the ability to prime T cells and this is done by licensing inw chi the T cell will upregulate surface CD40 which licenses the DC.
How to hide from cytotoxic T cells?
latency, antogenic variation, infect immune priviliged sites like the CNS, immunoevasins, produce antiapoptotic proteins, interfere with pathogen receptors.
How do DC avoid apoptosis?
express IAP
NK cells surface markers
CD56: adhesion,
CD16: FCgamma for IgG
KIR: Killer Cell Ig Receptor, recgonizes MHC
Subsets of NK cells
CD56 Bright/CD16 dim: release more cytokines, high proliferation, in sec. lymph. organs.

CD56dim/CD16bright: release more cytotoxins, loe proliferation, in blood
NK Cells Activating and Inhibitory Receptors
Inhibitory: recognize MHC class I, ITIM, and use phospatases to inhibit apoptosis.

Activating: virus and stress proteisn, ITAL, DAP 12 adpators

*most NK receptors can be expressed by an activated T cell